Drugs not eligible for Assumed Special Authority

The following medications continue to qualify for practitioner and specialty exemptions, but are not eligible for Assumed Special Authority.

abatacept & rituximab
adalimumab, etanercept & infliximab
ambrisentan
antibiotics
bosentan
botulinum toxin
clostridium botulinum neurotoxin type A
epoprostenol
insulin detemir
insulin glargine
investigational drugs
leuprolide
ondansetron
ophthalmic quinolones
sildenafil
treprostinil